Back

Mortality rates by therapeutic approaches for isolated severe tricuspid regurgitation: a systematic review.

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Tricuspid valve intervention: ready for prime time? Tricuspid Valve Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jules Mesnier

Hospital Bichat-Claude Bernard, Paris (France)

5 More presentations in this session

Presentation thumbnail
Echocardiographic pulmonary vascular resistance in patients undergoing tricuspid annuloplasty: prognostic implications and reversibility
Mr J. Zhang (Hong Kong, CN)
Abstract Slides Video
Presentation thumbnail
Characteristics and outcomes of patients with moderate multivalvular disease in the context of tricuspid regurgitation
Doctor M. Morosato (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Ventricular interaction and clinical outcomes in patients undergoing transcatheter tricuspid valve repair
Doctor T. Tanaka (Kawasaki, JP)
Abstract Slides Video
Presentation thumbnail
Different right ventricular mechanics in atrial and ventricular secondary tricuspid regurgitation and their prognostic role. A multicentric three-dimensional echocardiography study
Doctor B. Lakatos (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes according to clinical and surgical risk scores for tricuspid regurgitation
Assistant Professor S. Gwak (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Tricuspid valve intervention: ready for prime time?
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources